FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048693775> ?p ?o ?g. }

• W3048693775 endingPage "26" @default.
• W3048693775 startingPage "20" @default.
• W3048693775 abstract "Abstract Both therapy and prophylaxis for infectious complications during the treatment of acute myeloid leukemia (AML) have improved, although invasive fungal disease still remains a life‐threatening occurrence. Accordingly, prophylactic strategies with effective and well‐tolerated antifungals remain a cornerstone of management. Herein, the recent literature on antifungal prophylaxis used during the treatment of AML is reviewed, with a focus on the use in combination with midostaurin. The multikinase inhibitor midostaurin targets FMS‐like tyrosine kinase 3 (FLT3) and is approved, in association with 7 + 3, for the treatment of adult patients with newly diagnosed FLT3‐mutated AML. Midostaurin has been shown to extend both overall and event‐free survival in AML patients with an FLT3 mutation and is now the standard of care in FLT3+ AML. Antifungal prophylaxis should be adopted during all phases of treatment in all AML patients, and the strong CYP3A4 inhibitor posaconazole is frequently the preferred agent. As midostaurin is metabolized primarily by CYP3A4, there is a potential for drug–drug interactions that requires further evaluation. At present, the available data suggest that there are no absolute contraindications for coadministration of midostaurin with posaconazole, albeit with cautious monitoring. Considering the survival advantage offered by midostarin, concomitant administration of strong CYP3A4 inhibitors should not be ruled out, although such use should be evaluated cautiously and used on a case‐by‐case basis only if there are no suitable alternatives. It should also be kept in mind that patients with invasive fungal infection undergoing therapy for AML with midostaurin may need prolonged antifungal therapy, which must be based on the administration of the appropriate antifungal agent." @default.
• W3048693775 created "2020-08-18" @default.
• W3048693775 creator A5008526145 @default.
• W3048693775 creator A5025215179 @default.
• W3048693775 creator A5034666184 @default.
• W3048693775 creator A5039373089 @default.
• W3048693775 creator A5042609656 @default.
• W3048693775 creator A5054317101 @default.
• W3048693775 creator A5057593886 @default.
• W3048693775 date "2020-09-21" @default.
• W3048693775 modified "2023-09-24" @default.
• W3048693775 title "Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis" @default.
• W3048693775 cites W1608979960 @default.
• W3048693775 cites W1744167954 @default.
• W3048693775 cites W1968735244 @default.
• W3048693775 cites W1977267736 @default.
• W3048693775 cites W1983999811 @default.
• W3048693775 cites W1989267818 @default.
• W3048693775 cites W1989345554 @default.
• W3048693775 cites W1993300766 @default.
• W3048693775 cites W2014611012 @default.
• W3048693775 cites W2021759592 @default.
• W3048693775 cites W2036207753 @default.
• W3048693775 cites W2059806995 @default.
• W3048693775 cites W2108753267 @default.
• W3048693775 cites W2115707319 @default.
• W3048693775 cites W2118847922 @default.
• W3048693775 cites W2144322736 @default.
• W3048693775 cites W2145391043 @default.
• W3048693775 cites W2152273695 @default.
• W3048693775 cites W2154625299 @default.
• W3048693775 cites W2165549415 @default.
• W3048693775 cites W2461928138 @default.
• W3048693775 cites W2521621610 @default.
• W3048693775 cites W2557605278 @default.
• W3048693775 cites W2592434857 @default.
• W3048693775 cites W2625966229 @default.
• W3048693775 cites W2715749014 @default.
• W3048693775 cites W2734095947 @default.
• W3048693775 cites W2742352005 @default.
• W3048693775 cites W2761881371 @default.
• W3048693775 cites W2767526713 @default.
• W3048693775 cites W2772600186 @default.
• W3048693775 cites W2783024892 @default.
• W3048693775 cites W2793225437 @default.
• W3048693775 cites W2799390039 @default.
• W3048693775 cites W2799470600 @default.
• W3048693775 cites W2888806113 @default.
• W3048693775 cites W2895485327 @default.
• W3048693775 cites W2904378474 @default.
• W3048693775 cites W2909786583 @default.
• W3048693775 cites W2913796974 @default.
• W3048693775 cites W2922901737 @default.
• W3048693775 cites W2943849543 @default.
• W3048693775 cites W2946122440 @default.
• W3048693775 cites W2974308092 @default.
• W3048693775 doi "https://doi.org/10.1002/hon.2788" @default.
• W3048693775 hasPublicationYear "2020" @default.
• W3048693775 type Work @default.
• W3048693775 sameAs 3048693775 @default.
• W3048693775 citedByCount "0" @default.
• W3048693775 crossrefType "journal-article" @default.
• W3048693775 hasAuthorship W3048693775A5008526145 @default.
• W3048693775 hasAuthorship W3048693775A5025215179 @default.
• W3048693775 hasAuthorship W3048693775A5034666184 @default.
• W3048693775 hasAuthorship W3048693775A5039373089 @default.
• W3048693775 hasAuthorship W3048693775A5042609656 @default.
• W3048693775 hasAuthorship W3048693775A5054317101 @default.
• W3048693775 hasAuthorship W3048693775A5057593886 @default.
• W3048693775 hasConcept C126322002 @default.
• W3048693775 hasConcept C143998085 @default.
• W3048693775 hasConcept C16005928 @default.
• W3048693775 hasConcept C177713679 @default.
• W3048693775 hasConcept C2776481607 @default.
• W3048693775 hasConcept C2778461978 @default.
• W3048693775 hasConcept C2778566413 @default.
• W3048693775 hasConcept C2778729363 @default.
• W3048693775 hasConcept C2779384505 @default.
• W3048693775 hasConcept C2779548794 @default.
• W3048693775 hasConcept C2779629538 @default.
• W3048693775 hasConcept C71924100 @default.
• W3048693775 hasConcept C98274493 @default.
• W3048693775 hasConceptScore W3048693775C126322002 @default.
• W3048693775 hasConceptScore W3048693775C143998085 @default.
• W3048693775 hasConceptScore W3048693775C16005928 @default.
• W3048693775 hasConceptScore W3048693775C177713679 @default.
• W3048693775 hasConceptScore W3048693775C2776481607 @default.
• W3048693775 hasConceptScore W3048693775C2778461978 @default.
• W3048693775 hasConceptScore W3048693775C2778566413 @default.
• W3048693775 hasConceptScore W3048693775C2778729363 @default.
• W3048693775 hasConceptScore W3048693775C2779384505 @default.
• W3048693775 hasConceptScore W3048693775C2779548794 @default.
• W3048693775 hasConceptScore W3048693775C2779629538 @default.
• W3048693775 hasConceptScore W3048693775C71924100 @default.
• W3048693775 hasConceptScore W3048693775C98274493 @default.
• W3048693775 hasIssue "1" @default.
• W3048693775 hasLocation W30486937751 @default.
• W3048693775 hasOpenAccess W3048693775 @default.

• next